Based on current macro regime conditions and healthcare (xlv)'s historical behaviour in similar regimes, the model projects $151 by 2026-12-31 ( +1.2% from $149 today). The 68% confidence range is $135 to $168; the wider 95% range is $119 to $184. Methodology below the headline.
Healthcare (XLV) Forecast 2026
Quantitative analysis from 1,311 observations of Healthcare (XLV) history, joined to four universal macro regime classifications. Numbers are computed, not narrated.
Regime Scan[01/04]
Δ = divergence from +4.8% unconditional all-history average
Performance by Window[02]
| WINDOW | N | ANN RET | ANN VOL | RET/VOL | HIT % | TOTAL |
|---|---|---|---|---|---|---|
| 1Y | 267 | 12.70% | 14.04% | 0.90 | 45.9% | 12.69% |
| 3Y | 768 | 5.36% | 13.69% | 0.39 | 49.7% | 16.93% |
| 5Y | 1,271 | 4.22% | 14.55% | 0.29 | 50.5% | 22.95% |
| 10Y | 1,311 | 4.84% | 14.44% | 0.33 | 50.7% | 27.53% |
| All | 1,311 | 4.84% | 14.44% | 0.33 | 50.7% | 27.53% |
Annualized total return = (1 + total)^(1/years) - 1. Ret/Vol is the annualized return divided by annualized volatility (Sharpe-equivalent without risk-free subtraction). Hit % = pct of single periods that were positive.
Where We Are Now[03]
Forward Returns by Macro Regime[04]
How Healthcare (XLV) has performed historically conditional on the prevailing macro regime. The current bucket is highlighted; +1Y averages drive the headline signal above.
| REGIME BUCKET | N | +30D | +90D | +1Y AVG | +1Y MED | HIT % |
|---|---|---|---|---|---|---|
| Low (<15) | 261 | 1.62% | 2.34% | 3.48% | 3.13% | 67.8% |
| Normal (15-25) | 852 | -0.19% | 1.28% | 3.05% | 1.98% | 59.8% |
| Elevated (25-40) | 176 | 2.49% | 1.17% | 2.37% | 2.74% | 71.9% |
| Extreme (>40) | 4 | n/a | n/a | n/a | n/a | n/a |
| REGIME BUCKET | N | +30D | +90D | +1Y AVG | +1Y MED | HIT % |
|---|---|---|---|---|---|---|
| Inverted (<0bps) | 540 | 0.97% | 2.51% | 4.11% | 3.58% | 68.7% |
| Flat (0-100bps) | 581 | -0.34% | -0.32% | 2.25% | 2.51% | 62.5% |
| Steep (>100bps) | 163 | 2.10% | 3.77% | 1.44% | -0.12% | 49.7% |
| REGIME BUCKET | N | +30D | +90D | +1Y AVG | +1Y MED | HIT % |
|---|---|---|---|---|---|---|
| Tight (<350bps) | 772 | 0.51% | 1.45% | 0.26% | -0.37% | 48.2% |
| Normal (350-500bps) | 469 | 0.13% | 1.11% | 5.97% | 5.33% | 77.8% |
| Stressed (>500bps) | 53 | 4.67% | 5.46% | 5.87% | 4.24% | 92.5% |
| REGIME BUCKET | N | +30D | +90D | +1Y AVG | +1Y MED | HIT % |
|---|---|---|---|---|---|---|
| Weak (bottom tercile) | 125 | -0.02% | 3.35% | 4.07% | 4.36% | 77.8% |
| Neutral (middle) | 336 | 1.88% | 3.63% | 1.42% | -0.37% | 47.7% |
| Strong (top tercile) | 818 | 0.06% | 0.49% | 3.35% | 3.20% | 66.1% |
Forward returns are forward-looking from each historical observation in the bucket; +252d corresponds to one trading year. Buckets with fewer than 5 forward-return observations are reported as n/a. These are conditional historical averages, not forecasts.
Lead-Lag Relationships[05]
For each universally-recognised leading indicator, the lag at which the daily-return correlation peaks. Positive lag means the anchor leads Healthcare (XLV); negative means it lags.
| ANCHOR | ROLE | PEAK LAG | PEAK CORR | ZERO-LAG | RELATIONSHIP |
|---|---|---|---|---|---|
| VIX | Volatility leader | 0d | -0.488 | -0.488 | coincident |
| HY OAS Spread | Credit risk leader | 0d | -0.267 | -0.267 | coincident |
| Trade-Weighted Dollar | FX driver | 0d | -0.187 | -0.187 | coincident |
| Copper | Global growth proxy | 0d | 0.142 | 0.142 | weak |
| 10Y Treasury Yield | Discount-rate driver | +41d | -0.106 | -0.104 | weak |
| NFCI | Financial conditions | -13d | -0.100 | -0.076 | weak |
| Baa-10Y Spread | Credit risk (slow) | -37d | -0.093 | -0.018 | weak |
| 10Y-2Y Yield Spread | Recession leader | -46d | 0.084 | 0.004 | weak |
| Initial Jobless Claims | Labor leader | -22d | -0.067 | 0.025 | weak |
| U-Mich Consumer Sentiment | Survey leader | 0d | 0.000 | 0.000 | weak |
Pearson correlation of daily returns over up to 25 years of overlapping history, searched across a ±60-day lag grid. Indicators classified as “weak” don't have meaningful predictive power at daily resolution; many of these (yield curve, NFCI, sentiment) lead at monthly/quarterly horizons instead.
Historical Analogs[06]
Periods where Healthcare (XLV) sat at a similar percentile rank to today, with what happened over the next 30 / 90 / 252 trading days. Analogs are clustered to avoid double-counting nearby dates.
| DATE | VALUE | +30D | +90D | +1Y |
|---|---|---|---|---|
| Mar 31, 2025 | 146.0100 | -9.68% | -10.86% | 1.18% |
| Dec 9, 2024 | 144.7000 | -0.27% | -6.66% | 6.14% |
| Jul 8, 2024 | 144.2500 | 6.62% | 2.06% | -5.50% |
| Dec 29, 2023 | 136.3800 | 4.75% | 5.07% | 0.87% |
| Aug 29, 2023 | 134.9200 | -3.28% | 4.02% | 15.71% |
Worst Historical Drawdown[07]
Cross-Asset Correlations · 1Y[08]
Largest Single-Period Moves[09]
- Apr 9, 20254.35%
- Oct 1, 20253.09%
- Feb 25, 20223.06%
- Nov 10, 20222.54%
- May 12, 20252.47%
- Apr 4, 2025-5.48%
- Apr 22, 2022-3.65%
- Sep 13, 2022-3.30%
- Jun 13, 2022-3.03%
- May 13, 2025-3.01%
Calendar-Month Seasonality[10]
Average single-period return aggregated by the calendar month in which the period ended.
| MONTH | AVG RETURN | HIT % | N |
|---|---|---|---|
| January | 0.01% | 46.5% | 101 |
| February | 0.03% | 42.7% | 96 |
| March | -0.01% | 49.5% | 109 |
| April | -0.05% | 46.9% | 128 |
| May | -0.01% | 48.5% | 136 |
| June | 0.06% | 55.3% | 103 |
| July | 0.08% | 53.3% | 105 |
| August | 0.06% | 54.1% | 111 |
| September | -0.12% | 45.6% | 103 |
| October | 0.09% | 51.8% | 110 |
| November | 0.16% | 61.8% | 102 |
| December | 0.01% | 52.8% | 106 |
N = 1,311 OBS · GENERATED 2026-05-30 05:30Z
Forecast Approach
scenario weighted: We aggregate probability-weighted outcomes across active tracked scenarios, each with historical base rates and current heat scores. The projection above is the sample-weighted central estimate across current macro regime anchors; the scenario list below adds qualitative context.
Key Drivers & Risks
- •Sector rotation
- •Earnings cycle
- •Rate sensitivity
- •Macro regime
Historical Volatility
Moderate-high: sector dispersion varies by cycle
Scenarios That Affect This Forecast
How XLV Forecasts Have Held Up Historically
Healthcare sector forecasts have a moderate track record. XLV's defensive characteristics produce smaller drawdowns than the broader market in stress regimes (2008 -23% vs SPY -38%, 2020 -12% vs SPY -34%) but the sector has lagged in growth-led bull regimes (2023-2024 XLV +5% vs SPY +24%). Median absolute analyst miss is roughly 13% over 2010-2025.
Regime-conditional models on XLV achieve approximately 67% directional accuracy. Pharma earnings cyclicality is muted but biotech volatility, MedTech capex cycles, and managed care policy risk produce the residual error.
Regime Sensitivity for XLV
XLV has split regime sensitivity. Pharma (LLY, MRK, PFE, JNJ) is a defensive-growth blend; managed care (UNH, ELV, CI) is more cyclical and policy-sensitive; biotech (regional names, smaller weight) is highest-beta. Goldilocks regimes map to forward 252-day XLV returns averaging +10%; stagflation near -2%; reflation near +6%; deflation near +4%.
The April 2026 setup has XLV underperforming SPY year-to-date as GLP-1 demand peak fears (LLY) and managed care MA-rate pressure (UNH) weigh on the largest names. The regime conditional reads as moderately constructive on the defensive characteristics but with idiosyncratic risk concentrated in the top 10 names.
What Drives XLV Forecast Errors
Three structural issues drive XLV forecast errors. First, single-drug binary outcomes (FDA approvals, clinical trial results) move single-stock weights 10-20% in days; LLY's tirzepatide and Wegovy/Ozempic dynamics drove sector-level moves through 2023-2024.
Second, managed care (UNH 8% of XLV) is heavily exposed to Medicare Advantage rate decisions, Medicaid eligibility redeterminations, and political-cycle scrutiny. The 2024 UNH cyber-attack and the ongoing DOJ-MA fraud investigation produced 15-20% UNH moves that the regime classifier treats as residual.
Third, biotech is real-rate-sensitive in a way the model under-states. XBI (biotech ETF) has 2x the rate sensitivity of XLV; the rate shock of 2022 took XBI -28% while XLV held -2%.
How to Use This Forecast in Practice
For XLV, decompose by sub-sector. Pharma (60% weight) deserves a defensive-growth read; managed care (15% weight) deserves a cyclical-policy read; MedTech and biotech (25% combined) deserve a real-rate-and-innovation read.
The cleanest single cross-check is the XLV-XLP spread. Both are defensive but XLP is more rate-sensitive and consumer-cyclical; XLV is more idiosyncratic. XLV leading XLP signals defensive flows with growth-tilt; XLP leading signals rate-driven defensive rotation. The 68% band on XLV is roughly 90% of SPY's because of the defensive characteristics offset by the single-name binary risks.
Frequently Asked Questions
What factors could push Healthcare (XLV) higher?▾
The primary drivers that tend to lift Healthcare (XLV) depend on the current macro regime. Health Care Select Sector SPDR Fund. Convex tracks these drivers live across the Equity Sector category and flags when multiple forces align in the same direction. See the "Key Drivers & Risks" section on this page for the current list, and check the regime dashboard for how the macro backdrop is currently tilted.
What factors could push Healthcare (XLV) lower?▾
The same transmission channels that drive Healthcare (XLV) higher operate in reverse when conditions flip. The risk drivers listed above map directly to scenarios that, if triggered, would pull this metric in the opposite direction. Convex aggregates these into a scenario-weighted probability distribution rather than a point forecast, so the magnitude depends on which scenarios activate.
Where does consensus see Healthcare (XLV) heading?▾
Rather than publish a point target that goes stale the day after release, Convex assembles consensus from the macro regime classification, active scenario probabilities, and historical base rates. Point forecasts from banks and strategists are worth reading for context, but they typically cluster around the consensus and miss the tail events that actually move markets. The scenario-weighted approach here captures that tail risk explicitly.
What is the historical range for Healthcare (XLV)?▾
Historical ranges for Healthcare (XLV) vary dramatically by regime. A level that is extreme in Goldilocks can be routine in Stagflation, and vice versa. The Historical Volatility section on this page describes the typical range and regime-specific behavior. For the full multi-decade history, visit the Healthcare (XLV) chart page, which includes selectable time ranges up to five years and downloadable data.
How often is the Healthcare (XLV) forecast updated?▾
This forecast page recalculates whenever the underlying data or regime classification changes, typically within hours of new data releases. The scenario probabilities refresh daily as the macro state is regenerated. Specific drivers listed on this page reflect the current state of the Convex regime engine, not static historical assumptions.
Is this forecast actionable for trading?▾
Convex forecasts are informational and educational. They describe probability distributions and regime-conditional paths rather than specific entry and exit levels. Traders and portfolio managers use them alongside other inputs including position sizing rules, risk management, and their own conviction calibration. They are not investment advice.
Get forecast updates for Healthcare (XLV) and related indicators.
Forecasts are model-based projections derived from current regime classification, scenario probabilities, and historical patterns. They are not investment advice. All investments involve risk.